Effect of the novel antiplatelet agent cilostazol on plasma lipoproteins in patients with intermittent claudication

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 18, Issue 12, 1998, Pages 1942-1947

  Elam, M B ^a   Heckman, J ^b   Crouse, J R ^c   Hunninghake, D B ^e   Herd, J A ^f   Davidson, M ^g   Gordon, I L ^d   Bortey, E B ^b   Forbes, W P ^b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b OTSUKA PHARMACEUTICAL DEVELOPMENT AND COMMERCIALIZATION INC   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

^f Baylor Medical Center   (United States)

^g RADIANT RESEARCH   (United States)

Author keywords

ApoA1; Cilostazol; HDL; Intermittent claudication; Triglycerides

Indexed keywords

APOLIPOPROTEIN A1; CILOSTAZOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO;

ADULT; ARTICLE; DRUG EFFECT; ENZYME INHIBITION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTRIGLYCERIDEMIA; INTERMITTENT CLAUDICATION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PHYSICAL DISABILITY; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; TREADMILL EXERCISE;

EID: 0031649108     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.18.12.1942     Document Type: Article

References (10)

1. Kimura Y, Tani T, Kanbe T, Watanabe K. Effect of cilostazol on platelet aggregation and experimental thrombosis. Arzneimittelforschung. 1985; 35:1144-1149.
2. Ikeda Y, Kikuchi M, Murakami H, Satoh K, Murata M, Watanabe K, Ando Y. Comparison of the inhibitory effects of cilostazol, acetylsalicylic acid and ticlopidine on platelet functions ex vivo: randomized, double-blind cross-over study. Arzneimittelforschung. 1987;37:563-566.
3. Okuda Y, Yukio K, Kamejiro Y. Cilostazol. Cardiovasc Drug Rev. 1993;11:451-465.
4. Takazakura E, Ohsawa K, Hammamatusa K. Effect of cilostazol (Pletaal) on serum lipid levels in diabetic patients. Jpn Pharmacol Ther. 1989;17: 311-315.
5. Manual of Laboratory Operations: Lipid Research Clinics Program, Volume 1, Lipid and Lipoprotein Analyses. Bethesda, Md: National Heart and Lung Institute, National Institutes of Health; 1974. DHEW publication No (NIH)75-628. Revised 1982.
6. Burstein M, Samaille J. Sur un dosage rapide du cholesterol li aux et aux lipoprotines du srum. Clin Chim Acta. 1960;5:609.
7. Gidez LI, Miller GJ, Burstein M, Slagle S, Eder HA. Separation and quantitation of subclasses of human high density lipoproteins by a simple precipitation procedure. J Lipid Res. 1982;23:1206-1223.
8. Friedewald, WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
9. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Summary of the second report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel II). JAMA. 1993;269:3015-3023.
10. Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ, Browner D. Mortality over a period of ten years in patients with peripheral arterial disease. N Engl J Med. 1992;326:381-386.